典型文献
Qishen Taohong Granule as Adjuvant Therapy for Improving Cardiac Function and Quality of Life in Patients with Chronic Heart Failure:A Randomized Controlled Trial
文献摘要：
Objective:To confirm the improvement of cardiac function and quality of life (QoL) in patients with chronic heart failure (CHF) via Chinese medicine (CM) Qishen Taohong Granule (QTG).Methods:This study was a single-center,prospective,randomized,controlled clinical trial.Seventy-six patients from 27 to 84 years old diagnosed with CHF New York Heart Association (NYHA) class Ⅱ or Ⅲ in stage C were enrolled and randomly assigned at a 1∶1 ratio to receive QTG or trimetazidine (TMZ),in addition to their standard medications for the treatment of CHF.The study period was 4 weeks.The primary outcomes included cardiac function evaluated by NYHA classification and left ventricular ejection fraction (LVEF),as well as QoL evaluated by CHF Integrated Chinese and Western Medicine Survival Scale (CHFQLS).The secondary outcomes included 6-min walking test (6MWT),CM syndrome score,symptom and sign scores and N-terminal pro-B-type natriuretic peptide level (NT-proBNP).All indices were measured at baseline and the end of the trial.Results:At the 4-week follow-up period,the effective rate according to NYHA classification in the QTG group was better than that in the TMZ group (74.29％ vs.54.29％,P＜0.05).But there was no significant difference in post-treatment level of LVEF between the two groups (P＞0.05).The CHFQLS scores improved by 13.82 ± 6.04 vs.7.49± 2.28 in the QTG and TMZ groups,respectively (P＜0.05).Subgroup analysis of the CHFQLS results showed that physiological function,role limitation and vitality were significantly higher in the QTG group than in the TMZ group (15.76±7.85 vs.7.40±3.36,P＜0.05;16.00±8.35 vs.10.53±4.64,P＜0.05;15.31 ±8.09 vs.7.89± 4.60,P＜0.05).Compared with TMZ group,treatment with QTG also demonstrated superior performance with respect to 6MWT,CM syndrome,shortness of breath,fatigue,gasping,general edema and NT-proBNP level.No significant adverse reactions or adverse cardiac events occurred during treatment in either group.Conclusion:In addition to conventional treatments,the use of QTG as an adjuvant therapy significantly improved cardiac function and QoL in patients with CHF class Ⅱ or Ⅲ in stage C.[Registration No.ChiCTR1900022036 (retrospectively registered)]
文献关键词：
中图分类号：
作者姓名：
LI Xing-xing;WU Yang;FAN Zong-jing;CUI Jie;LI Dong;LIN Quan;ZHUANG Rui;YAN Rong-kun;LIN Qian;LI Yan
作者机构：
Department of Graduate School,Beijing University of Chinese Medicine,Beijing 100029 ,China;Department of Cardiology,Dongfang Hospital,Beijing University of Chinese Medicine,Beijing 100078 ,China;Department of Cardiology,Xiyuan Hospital,China Academy of Chinese Medical Sciences,Beijing 100091 ,China;Department of Cardiology,Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing 100700 ,China
文献出处：
引用格式：
[1]LI Xing-xing;WU Yang;FAN Zong-jing;CUI Jie;LI Dong;LIN Quan;ZHUANG Rui;YAN Rong-kun;LIN Qian;LI Yan-.Qishen Taohong Granule as Adjuvant Therapy for Improving Cardiac Function and Quality of Life in Patients with Chronic Heart Failure:A Randomized Controlled Trial)[J].中国结合医学杂志（英文版）,2022(01):12-19
A类：
Qishen,QTG,CHFQLS,gasping,ChiCTR1900022036
B类：
Taohong,Granule,Adjuvant,Therapy,Improving,Cardiac,Function,Quality,Life,Patients,Chronic,Heart,Failure,Randomized,Controlled,Trial,Objective,To,confirm,improvement,cardiac,function,quality,life,QoL,patients,chronic,heart,failure,via,Chinese,medicine,CM,Methods,This,study,was,single,center,prospective,randomized,controlled,clinical,trial,Seventy,six,from,years,old,diagnosed,New,York,Association,NYHA,stage,were,enrolled,randomly,assigned,receive,trimetazidine,TMZ,addition,their,standard,medications,period,weeks,primary,outcomes,included,evaluated,by,classification,left,ventricular,ejection,fraction,LVEF,well,Integrated,Medicine,Survival,Scale,secondary,walking,test,6MWT,syndrome,symptom,scores,terminal,type,natriuretic,peptide,level,NT,proBNP,All,indices,measured,baseline,end,Results,At,follow,effective,according,better,than,that,But,there,difference,post,between,two,groups,improved,respectively,Subgroup,analysis,results,showed,physiological,role,limitation,vitality,significantly,higher,Compared,also,demonstrated,superior,performance,shortness,breath,fatigue,general,edema,No,adverse,reactions,events,occurred,during,either,Conclusion,conventional,treatments,use,adjuvant,therapy,Registration,retrospectively,registered
AB值：
0.514703
相似文献
机标中图分类号，由域田数据科技根据网络公开资料自动分析生成，仅供学习研究参考。
